Estrella Immunopharma, Inc. Common Stock (ESLA) is a publicly traded Healthcare sector company. As of October 26, 2026, ESLA trades at $1.01 with a market cap of $42.85M and a P/E ratio of -1.04. ESLA moved +4.57% today. Year to date, ESLA is -36.86%; over the trailing twelve months it is -57.73%. Its 52-week range spans $0.24 to $3.15. Rallies surfaces ESLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ESLA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.01 |
| Market Cap | $42.85M |
| P/E Ratio | -1.04 |
| EPS | $-0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.15 |
| 52-Week Low | $0.24 |
| Volume | 1.42M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.06M |
| Gross Margin | 0.00% |
ESLA analyst coverage data. Average price target: $0.00.